Swanbridge Capital
Overview
Swanbridge Capital is a Rotterdam-based venture capital firm specializing in early-stage investments within the life sciences sector. The firm focuses on (pre-)seed investments in the development of novel therapies, diagnostics, and medical devices. Established in 2016, Swanbridge Capital is funded by Van Herk Investments, the Erasmus Medical Center, and the City of Rotterdam, aiming to create a vibrant life science ecosystem by bridging the gap between invention and proof of concept. The firm's investment strategy emphasizes active collaboration with portfolio companies, leveraging their extensive experience in early-stage development and a strong presence in the Rotterdam ecosystem. Swanbridge Capital's team comprises professionals with complementary expertise in business development, enabling them to provide valuable support to their investees. Their approach is rooted in the belief that close cooperation is key to success, combining innovative ideas with business acumen to foster growth. Swanbridge Capital's portfolio includes investments in companies such as Pan Cancer, Flindr Therapeutics, and Allero Therapeutics. Their most recent investment was in Pan Cancer on July 11, 2024, during a seed round. The firm has a history of supporting companies that are in the early stages of development and still need to generate proof of concept for their technology, reflecting their commitment to nurturing high-potential life sciences startups across Europe.
Investment Focus
- Early-stage life sciences companies
- Focus on novel therapies, diagnostics, and medical devices
- Strong potential for growth and innovation
- Alignment with Swanbridge Capital's strategic objectives
Portfolio Companies
Reach Swanbridge Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Swanbridge Capital
What sectors does Swanbridge Capital invest in?
Swanbridge Capital invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Zuid-Holland, Netherlands. Swanbridge Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Swanbridge Capital invest at?
Swanbridge Capital backs companies at Seed and Early Stage, writing cheques of 500K - 5M.
Which regions does Swanbridge Capital invest in?
Swanbridge Capital invests across United Kingdom, Germany, France, Italy, Denmark and Switzerland.
What companies has Swanbridge Capital invested in?
Swanbridge Capital's portfolio includes Flindr Therapeutics, Pan Cancer and Allero Therapeutics.
How do I contact Swanbridge Capital?
Swanbridge Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
